Cambridge spin-out company wins £18m to fight Alzheimer's
Wren Therapeutics secures £18 million in funding to tackle protein misfolding diseases.
Wren Therapeutics secures £18 million in funding to tackle protein misfolding diseases.
© 2026 University of Cambridge